Defendant Name: American Renal Associates Holdings, Inc.

Defendant Type: Public Company

Document Reference: court_doc11_21-cv-10366

Document Details

Legal Case Name SEC v. American Renal Associates Holdings, Inc., Jonathan L. Wilcox, Jason M. Boucher, Karen J. Smith
Document Name Final Judgment as to Defendant American Renal Associates Holdings, Inc.
Document Date 08-Dec-2021
Document Format Civil Proceeding
Case Number 21-cv-10366
Federal District Court New York, Southern District of New York
Federal District Judge J. Paul Oetken
Allegation Type Issuer Reporting and Disclosure
Document Summary The Court stated: "Defendant American Renal Associates Holdings, Inc. (“Defendant”) . . . consented to the Court’s jurisdiction over Defendant and the subject matter of this action; consented to entry of this Final Judgment without admitting or denying the allegations of the Complaint (except as to jurisdiction); waived findings of fact and conclusions of law; and waived any right to appeal from this Final Judgment."

Disgorgement & Penalty Information

Resolutions
Enjoinment
Monetary Penalties:

Civil Penalty

Individual:     $2,000,000.00 Shared:    

Related Documents:

comp-pr2021-252 06-Dec-2021 Complaint
Complaint
The SEC stated: "This is an accounting fraud case arising from a multimillion dollar scheme by three former ARA finance executives--Wilcox, Boucher, and Smith--to improperly manipulate certain revenue adjustments to make it appear that ARA's financial performance was better than it actually was."
LR-25282 06-Dec-2021 Litigation Release
SEC Charges Dialysis Provider and Three Former Senior Executives with Revenue Manipulation Scheme
The SEC stated: "[It] charged American Renal Associates Holdings, Inc. (ARA), a provider of dialysis services through clinics across the country, with engaging in a revenue manipulation scheme that resulted in the restatement of several years of financial reporting. The SEC also charged two of ARA's former chief financial officers, Jonathan Wilcox and Jason Boucher, and former ARA Controller, Karen Smith, for their misconduct related to the scheme."
2021-252 06-Dec-2021 Press Release--Civil Action
SEC Charges Dialysis Provider and Three Former Senior Executives with Revenue Manipulation Scheme
The SEC stated that: "[It] charged American Renal Associates Holdings, Inc. (ARA), a provider of dialysis services through clinics across the country, with engaging in a revenue manipulation scheme that resulted in the restatement of several years of financial reporting. The SEC also charged two of ARA’s former chief financial officers, Jonathan Wilcox and Jason Boucher, and former ARA Controller, Karen Smith, for their misconduct related to the scheme."

Other Defendants in Action: